To the question of PSA specificity as a tumor marker of prostate cancer
AUTHORS : Malintsev G.S.
RELEVANT UNIVERSITIES : “Eliseeva Medical Center”, Moscow, Russia
YEAR : 2010
Prostate cancer (PC) is one of the most common malignant neoplasms in middle-aged and elderly men. From the late 1970s to the early 1990s, the incidence of prostate cancer nearly doubled. In 2000, 180,400 new cases of prostate cancer were registered in the United States and 31,900 patients died from this disease, in Europe – 200,000 and 40,000, respectively. In the structure of oncological diseases in a number of
countries
